Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FBRSQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,696
Award facts
- Contract value 100% obligated
- $72,696.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,696.06 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units). The contract features firm fixed pricing and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026.
Vraylar is a neurological medication used to treat conditions including bipolar disorder and schizophrenia. As a critical pharmaceutical supplier to federal military and veteran healthcare systems, AmerisourceBergen Drug Corp serves the Defense Health Agency and other government healthcare entities through its comprehensive IDC vehicle, which enables the supply of brand-name and generic drugs, vaccines, specialty medications, and related medical supplies globally. The firm fixed pricing structure and rapid completion timeline reflect standard practices for pharmaceutical delivery orders supporting military medical supply chains under the DLA's established procurement framework.
Quick answers
Who was awarded contract SPE2DB25FBRSQ?
SPE2DB25FBRSQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FBRSQ worth?
The government has obligated $72,696 on SPE2DB25FBRSQ.
Is contract SPE2DB25FBRSQ an order under another contract?
Yes. SPE2DB25FBRSQ is a delivery order under SPE2DB24D2011, an indefinite delivery contract.
Was contract SPE2DB25FBRSQ competed?
The extent of competition for SPE2DB25FBRSQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award